American measles vaccine won’t hit Indian market without trials
April 27th, 2010 - 5:15 pm ICT by IANSNew Delhi, April 27 (IANS) An inhalable vaccine for measles which has been developed by scientists at the University of Colorado will not hit the Indian market any time soon, the government said Tuesday adding that clinical trials would be needed first.
“A dry powder inhalable measles vaccine has been developed by scientists from the University of Colorado, USA. The government of India is following the development of this inhalable vaccine and a decision on its suitability for Indian conditions would be considered when more evidence has been generated about its effectiveness and efficiency,” Minister of State for Health and Family Welfare Dinesh Trivedi told the Rajya Sabha in a written statement.
For the vaccine, the minister said a “carbon dioxide assisted nebuliser with a bubble dryer process technology has been used”.
“This technology is still in developmental stages and would need to go through various phases of clinical trials before it can be made available in the market,” Trivedi added.
The minister further said that “inhalation of dry powder has potential benefits of easier logistics of administration, reduced cold chain dependence and avoids risk associated with injections. No published data, however, is available on the safety and immunogenicity of dry powder inhalable measles vaccine.”
- New measles vaccine that can be inhaled shows promise - Feb 02, 2011
- Indian trial for inhalable measles vaccine offers hope for other diseases - May 06, 2010
- First inhalant powder measles vaccine to undergo clinical trials in India next year - Aug 17, 2009
- Measles vaccine inhaler shows promise - Sep 29, 2009
- Clinical trial on for inhalable measles vaccine - Dec 04, 2009
- India to test first dry powder vaccine for measles - Aug 17, 2009
- Jab-free HPV vaccine 'more effective, cheaper' for developing nations - Nov 18, 2010
- Chinese scientists a step closer to creating HIV vaccine - Apr 04, 2011
- Inhalable dry powder antibiotic may reduce TB treatment time - Nov 17, 2010
- First vaccine against kala azar ready for trial - Feb 22, 2012
- First vaccine for viral hepatitis C may soon become a reality - Apr 02, 2011
- THSTI,IAVI announce new HIV vaccine design program in India - Mar 04, 2011
- Symposium shows progress in TB vaccines - Jun 08, 2010
- Cuba to test new AIDS vaccine - Mar 07, 2012
- Will a female birth control vaccine work? - Mar 13, 2011
Tags: carbon dioxide, cold chain, colorado usa, dependence, developmental stages, effectiveness and efficiency, family welfare, government of india, immunogenicity, inhalation, logistics, measles vaccine, minister of state, New Delhi, phases of clinical trials, process technology, rajya sabha, scientists, suitability, university of colorado